Esposito Pamela is Chief Business Officer of Replimune Group Inc.
Person profile
Roles
Replimune
Chief Business Officer
Kymera Therapeutics
Director
Address
Woburn, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Replimune Group, Inc.
18 May 23
4
Replimune Group, Inc.
4 Apr 23
4
Replimune Group, Inc.
13 Dec 22
4
Kymera Therapeutics, Inc.
16 Jun 22
4
Replimune Group, Inc.
18 May 22
4
Replimune Group, Inc.
5 Apr 22
4
Replimune Group, Inc.
6 Aug 21
4
Replimune Group, Inc.
22 Jul 21
4
Replimune Group, Inc.
19 Jul 21
4/A
Replimune Group, Inc.
19 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | No | 18.05 | 5,966 | 107.69 k | 263,436 |
1 Apr 23 | REPL Replimune | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 269,402 |
1 Apr 23 | REPL Replimune | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 17.66 | 60,000 | 1.06 mm | 60,000 |
9 Dec 22 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 25.03 | 15,000 | 375.45 k | 229,402 |
9 Dec 22 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 1.01 | 15,000 | 15.15 k | 244,402 |
9 Dec 22 | REPL Replimune | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.01 | 15,000 | 15.15 k | 36,203 |
15 Jun 22 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.18 | 12,000 | 170.16 k | 12,000 |
16 May 22 | REPL Replimune | Common Stock | Sell | Dispose S | No | No | 14.59 | 3,507 | 51.17 k | 229,402 |